This classification is important because it affects almost every part of the Malaysia medical device registration process, including:
- Registration route;
- Technical documentation requirements;
- Conformity assessment requirements;
- MDA government fees;
- Estimated registration timeline;
- Product grouping strategy;
- Post-market obligations;
- Commercial launch planning.
This article explains the difference between Class A, B, C and D medical devices in Malaysia, and what foreign manufacturers should consider before starting MDA registration.
Malaysia regulates medical devices under the Medical Device Act 2012, also known as Act 737.
MDA states that no medical device shall be imported, exported, or placed in the Malaysian market unless the medical device is registered under the Act. MDA also defines medical devices broadly to include instruments, apparatus, machines, appliances, implants, in vitro reagents, calibrators, software, materials and similar articles intended for medical or diagnostic purposes.
Because medical devices can range from simple wound dressings to implantable cardiac devices, Malaysia uses risk-based classification to determine how much regulatory control is needed.
A low-risk device does not require the same level of review as a high-risk implantable device. This is why correct classification is the foundation of the registration process.
MDA’s classification guidance states that medical devices are categorized into four risk classes ranging from low to high risk: Class A, Class B, Class C and Class D. The actual classification depends on the manufacturer’s claims and the intended use of the device.
A simplified explanation is:
| Risk Class | Risk Level | General Meaning |
| Class A | Low risk | Simple, low-risk devices |
| Class B | Low to moderate risk | Devices with moderate safety considerations |
| Class C | Moderate to high risk | Devices with higher patient or user risk |
| Class D | High risk | High-risk, life-supporting, implantable, or critical devices |
Medical device classification in Malaysia is based on risk. The classification depends on several factors, including:
- Intended use;
- Claims made by the manufacturer;
- Duration of contact with the body;
- Whether the device is invasive or non-invasive;
- Whether the device is surgically invasive;
- Whether the device contacts the central circulatory system or central nervous system;
- Whether the device is active or non-active;
- Whether the device delivers energy or medicinal substances;
- Whether the device is implantable;
- Whether the device is sterile or has a measuring function;
- Whether the device is an in vitro diagnostic medical device;
- Whether failure of the device could result in serious harm.
This means classification cannot be decided only by product name. The same type of product may fall into different classes depending on its intended use, technology, claims, and patient contact.
MDA provides examples of risk classes for general medical devices. Examples listed by MDA include simple wound dressings and stethoscopes for Class A, hydrogel dressings and hearing aids for Class B, lung ventilators and deep wound dressings for Class C, and pacemakers, heart valves and stents for Class D.
| Class | Risk Level | Example Product Types |
| Class A | Low risk | Simple surgical instruments, tongue depressors, liquid-in-glass thermometers, examination lights, simple wound dressings, oxygen masks, stethoscopes, walking aids |
| Class B | Low to moderate risk | Hypodermic needles, suction equipment, anesthetic breathing circuits, aspirators, hearing aids, hydrogel dressings, phototherapy units, x-ray films |
| Class C | Moderate to high risk | Lung ventilators, orthopedic implants, baby incubators, blood oxygenators, blood bags, deep wound dressings, defibrillators, radiological therapy equipment |
| Class D | High risk | Pacemakers and leads, implantable defibrillators, implantable infusion pumps, heart valves, intra-uterine contraceptive devices, neurological catheters, vascular prostheses, stents |
Class A medical devices are low-risk devices.
These may include simple non-invasive products, basic reusable instruments, or other devices with low potential risk to patients and users.
Common Class A Characteristics
Class A devices are usually:
- Low risk;
- Simple in design;
- Non-invasive or minimally complex;
- Not life-supporting;
- Not implantable;
- Not used for critical monitoring;
- Not intended to deliver high-risk therapy.
Examples may include:
- Simple surgical instruments;
- Tongue depressors;
- Basic examination lights;
- Simple wound dressings;
- Stethoscopes;
- Walking aids;
- Oxygen masks.
Class A registration is generally more straightforward compared with Class B, C and D devices.
MDA’s classification document indicates that Class A devices are exempted from conformity assessment procedures by a CAB, while Class B, C and D devices require involvement of conformity assessment procedures.
This is one of the biggest differences between Class A and higher-risk devices.
Practical Timeline Estimate
As a practical planning estimate, Class A medical devices with recognized reference agency approvals or strong supporting documents may take around 2 to 3 months, depending on dossier readiness, application completeness, grouping and MDA processing.
This should not be presented as a guaranteed approval timeline, but it is useful for commercial planning.
Class B medical devices are low to moderate risk.
These devices may have more direct patient contact or greater technical complexity than Class A devices.
Common Class B Characteristics
Class B devices may:
- Have moderate risk to patients or users;
- Be invasive for limited use;
- Be active but not high-risk;
- Require more technical documentation than Class A;
- Require conformity assessment;
- Require stronger labelling and IFU review.
Examples may include:
- Hypodermic needles;
- Suction equipment;
- Anesthetic breathing circuits;
- Hearing aids;
- Hydrogel dressings;
- Phototherapy units;
- X-ray films.
Compared with Class A, Class B devices usually require more documentation and may involve conformity assessment by a registered conformity assessment body.
The manufacturer should prepare:
- Device description;
- Intended use;
- Product specifications;
- Essential principles checklist;
- Risk analysis;
- Clinical or performance evidence;
- Labelling and IFU;
- ISO 13485 certificate;
- Declaration of conformity;
- Reference approval documents, where applicable;
- Test reports, where applicable;
- Post-market history.
As a practical planning estimate, Class B devices with recognized reference agency approval may take around 4 to 6 months, while Class B devices without reference agency approval may take around 6 to 9 months, depending on dossier quality, CAB review, MDA queries and product complexity.
Class C medical devices are moderate to high-risk devices.
These devices generally require more detailed technical review because they may be used in more critical clinical situations or have greater potential impact on patient safety.
Common Class C Characteristics
Class C devices may:
- Be used for higher-risk treatment or monitoring;
- Be active therapeutic or diagnostic devices;
- Have more complex design or technology;
- Contact critical body systems;
- Be implant-related or clinically significant;
- Require detailed clinical or performance evidence;
- Require conformity assessment by a CAB.
Examples may include:
- Lung ventilators;
- Orthopedic implants;
- Baby incubators;
- Blood oxygenators;
- Blood bags;
- Deep wound dressings;
- Defibrillators;
- Radiological therapy equipment.
Class C registration is typically more complex than Class B because the risk level is higher.
Manufacturers should expect a stronger review of:
- Risk management;
- Clinical evaluation;
- Performance evidence;
- Biocompatibility, where applicable;
- Sterilization validation, where applicable;
- Electrical safety and EMC, where applicable;
- Software validation, where applicable;
- Shelf-life and packaging validation;
- Labelling claims;
- Post-market safety history.
As a practical planning estimate, Class C devices with recognized reference agency approval may take around 4 to 6 months, while Class C devices without reference agency approval may take around 6 to 9 months or longer if the dossier requires major gap closure.
For Class C devices, manufacturers should be careful not to overpromise launch dates to distributors before the technical file is reviewed.
Class D medical devices are high-risk devices.
These products may be life-supporting, life-sustaining, implantable, or used in critical clinical situations where device failure could result in serious harm.
Common Class D Characteristics
Class D devices may:
- Be high-risk implantable devices;
- Support or sustain life;
- Contact the central circulatory system or central nervous system;
- Be used in critical diagnosis or treatment;
- Have serious consequences if they fail;
- Require extensive clinical evidence;
- Require robust risk management and post-market data.
Examples may include:
- Pacemakers and leads;
- Implantable defibrillators;
- Implantable infusion pumps;
- Heart valves;
- Intra-uterine contraceptive devices;
- Neurological catheters;
- Vascular prostheses;
- Stents.
Class D devices usually require the most detailed regulatory review.
Manufacturers should prepare a complete and well-organized technical file, including:
- Full device description;
- Design and manufacturing information;
- Risk management file;
- Clinical evaluation or clinical investigation evidence;
- Biocompatibility data;
- Sterilization validation, where applicable;
- Shelf-life data;
- Packaging validation;
- Electrical safety and EMC reports, where applicable;
- Software validation, where applicable;
- Usability and human factors data, where applicable;
- Post-market surveillance data;
- Adverse event and recall history;
- Reference agency approvals, where applicable.
As a practical planning estimate, Class D devices with recognized reference agency approval may take around 4 to 6 months, while Class D devices without reference agency approval may take around 6 to 9 months or longer depending on complexity, CAB review and MDA queries.
For high-risk devices, manufacturers should always plan conservatively.
| Area | Class A | Class B | Class C | Class D |
| Risk level | Low | Low to moderate | Moderate to high | High |
| Technical documentation | Basic to moderate | Moderate | Detailed | Most detailed |
| CAB conformity assessment | Generally exempted | Usually required | Usually required | Usually required |
| Review complexity | Lowest | Moderate | High | Highest |
| Clinical evidence expectation | Lower | Moderate | Higher | Highest |
| Typical timeline complexity | Shorter | Medium | Longer | Longest |
| Government fee | Lowest | Higher than Class A | Higher than Class B | Higher than Class C |
| Commercial planning risk | Lower | Moderate | Higher | Highest |
MDA’s MeDC@St fee information lists different application and registration fees according to medical device class. The application fee is RM500 for Class A, RM250 for Class B, RM500 for Class C and RM750 for Class D. The registration fee is RM 750 for Class A, RM1,000 for Class B, RM2,000 for Class C and RM3,000 for Class D.
| Medical Device Class | Application Fee | Registration Fee |
| Class A | RM500 | RM750 |
| Class B | RM250 | RM1,000 |
| Class C | RM500 | RM2,000 |
| Class D | RM750 | RM3,000 |
| Medical device containing medicinal product | RM750 | RM5,000 |
- AR or license holder fee;
- Regulatory consulting fee;
- CAB conformity assessment fee;
- Technical document gap review;
- Translation, if applicable;
- Product grouping assessment;
- Change notification or maintenance fees;
- Distributor coordination support.
The higher the device class, the more detailed the technical documentation usually needs to be.
Class A Documentation
Class A documentation may include:
- Product description;
- Intended use;
- Device classification rationale;
- Product label;
- IFU, where applicable;
- Manufacturer information;
- Basic safety information.
Class B documentation may include all Class A documents plus:
- Risk analysis;
- Essential principles checklist;
- ISO 13485 certificate;
- Declaration of conformity;
- Test reports, where applicable;
- Clinical or performance evidence;
- Reference approvals, where applicable.
Class C documentation may require deeper technical evidence, including:
- Full risk management report;
- Clinical evaluation report;
- Biocompatibility data, where applicable;
- Sterilization validation, where applicable;
- Shelf-life and packaging validation;
- Electrical safety and EMC reports, where applicable;
- Software validation, where applicable;
- Post-market history.
Class D documentation is usually the most extensive and may include:
- Full design and manufacturing information;
- Robust clinical evidence;
- Detailed risk management;
- Complete safety and performance testing;
- Extensive post-market surveillance data;
- Adverse event and recall history;
- Strong justification of benefit-risk profile.
The device class can significantly affect the Malaysia registration timeline.
As a practical planning estimate:
| Device Class / Route | Indicative Planning Timeline |
| Class A | Around 2 to 3 months |
| Class B, C and D with recognized reference agency approval | Around 4 to 6 months |
| Class B, C and D without recognized reference agency approval | Around 6 to 9 months |
- Product classification;
- Product grouping;
- Technical file completeness;
- CAB review;
- MDA queries;
- Reference approval eligibility;
- Labelling readiness;
- Manufacturer response time.
Conformity assessment is one of the biggest differences between Class A and higher-risk devices.
MDA’s classification guidance indicates that Class A devices are exempted from CAB conformity assessment procedures, while Class B, C and D devices require involvement of conformity assessment procedures.
For Class B, C and D devices, the CAB may review:
- Technical documentation;
- Quality management system certification;
- Product safety and performance evidence;
- Clinical evidence;
- Risk management;
- Labelling and IFU;
- Post-market history;
- Reference approvals, where applicable.
Classification can also affect product grouping.
Product grouping determines whether multiple product models, sizes or variants can be submitted under one registration application.
Factors that may affect grouping include:
- Intended use;
- Risk class;
- Design;
- Technology;
- Materials;
- Manufacturing site;
- Sterility;
- Accessories;
- Brand;
- Product family structure.
Foreign manufacturers should complete grouping assessment before confirming project cost, timeline or distributor launch plans.
For foreign manufacturers, medical device classification affects more than regulatory submission.
It also affects commercial strategy.
Class A Strategy
Class A products may be faster and lower cost to register, making them suitable for early market entry or distributor testing.
However, manufacturers should still ensure that the classification is correct and that the appointed local representative understands the process.
Class B Strategy
Class B products require more preparation. The manufacturer should confirm whether reference approvals are available and whether the dossier is complete.
Class C Strategy
Class C products require stronger technical and clinical evidence. The manufacturer should avoid promising launch timelines before CAB and dossier requirements are confirmed.
Class D Strategy
Class D products require the most careful planning. The manufacturer should prepare for detailed regulatory review, strong evidence requirements and more conservative launch planning.
Classification should also influence the manufacturer’s decision on whether to let a distributor hold the registration.
For low-risk Class A devices, some manufacturers may be comfortable allowing a distributor to handle registration.
However, for Class B, C and D devices, the registration has higher regulatory and commercial value. Manufacturers may prefer appointing an independent AR / medical device license holder to maintain long-term control.
An independent license holder can help the manufacturer:
- Avoid distributor lock-in;
- Appoint multiple distributors;
- Change distributors if performance is weak;
- Maintain regulatory continuity;
- Separate regulatory control from commercial sales;
- Protect long-term market access.
Mistake 1: Assuming Product Name Determines Classification
Classification depends on intended use, claims, design and risk - not just product name.
For example, a “wound dressing” may fall into different classes depending on whether it is a simple dressing, hydrogel dressing or deep wound dressing.
Mistake 2: Using EU or FDA Classification Without Local Review
Foreign classification can be helpful, but Malaysia classification should still be assessed under Malaysian rules.
Mistake 3: Ignoring Intended Use Claims
Marketing claims can affect classification. Stronger claims may increase regulatory expectations.
Mistake 4: Grouping Products Without Checking Risk Class
Products with different risk classes may not be groupable under one application.
Mistake 5: Underestimating Class C or D Documentation
Higher-risk devices require stronger technical and clinical evidence.
Mistake 6: Allowing Distributor Registration Without Considering Long-Term Control
If the distributor holds the registration, the manufacturer may face difficulty changing distributors later.
Mistake 7: Not Reviewing Borderline Products Early
Products that sit between medical device, cosmetic, pharmaceutical, health supplement or general wellness categories should be assessed carefully before registration planning.
Some products require extra classification review because they may fall between regulatory categories.
Examples include:
- Wound care products with active ingredients;
- Skin repair or scar management products;
- Aesthetic devices;
- Disinfection products;
- Software and mobile health applications;
- Wellness monitoring devices;
- Dental products;
- Diagnostic kits;
- Combination products;
- Products containing medicinal substances.
- Is the product considered a medical device in Malaysia?
- Is it a general medical device or IVD?
- What is the intended use?
- What claims are made in brochures, IFU and labelling?
- Is the device invasive or non-invasive?
- Is it active or non-active?
- Is it sterile or measuring?
- Does it contact the central circulatory system or central nervous system?
- Is it implantable?
- Does it contain a medicinal substance?
- What is the correct Class A, B, C or D classification?
- Is conformity assessment required?
- Does the product have recognized reference agency approval?
- Can the models be grouped under one application?
- Should the registration be held by an independent license holder or distributor?
1. What are Class A, B, C and D medical devices in Malaysia?
Malaysia classifies medical devices into Class A, B, C and D based on risk, ranging from low risk to high risk. MDA’s classification guidance states that the actual classification depends on the manufacturer’s claims and intended use.
2. Which medical device class is the lowest risk?
Class A is the lowest-risk medical device class in Malaysia.
3. Which medical device class is the highest risk?
Class D is the highest-risk medical device class in Malaysia. Examples may include pacemakers, implantable defibrillators, heart valves and stents.
4. Does Class A require CAB conformity assessment?
MDA’s classification guidance indicates that Class A devices are exempted from conformity assessment procedures by a CAB, while Class B, C and D devices require involvement of conformity assessment procedures.
5. Do Class B, C and D devices require more documentation?
Yes. Class B, C and D devices usually require more technical documentation than Class A devices, including risk analysis, clinical or performance evidence, test reports, quality management system evidence and labelling information.
6. What are the MDA fees by class?
MDA lists application fees of RM500 for Class A, RM250 for Class B, RM500 for Class C and RM750 for Class D. Registration fees listed are RM 750 for Class A, RM1,000 for Class B, RM2,000 for Class C and RM3,000 for Class D.
7. How long does Malaysia medical device registration take by class?
As a practical planning estimate, Class A devices may take around 2 to 3 months, Class B, C and D devices with reference agency approval may take around 4 to 6 months, and Class B, C and D devices without reference agency approval may take around 6 to 9 months. Actual timelines depend on document readiness, CAB review, MDA queries, grouping and product complexity.
8. Can the same product type have different classifications?
Yes. Classification depends on intended use, claims, design, invasiveness, duration of use and risk. For example, different types of wound dressings may fall into different classes depending on their use and risk profile.
9. Should a foreign manufacturer use an independent license holder for higher-risk devices?
For Class B, C and D devices, an independent AR or license holder is often more strategic because it helps the manufacturer maintain registration control and avoid distributor lock-in.
10. Can foreign classification be used directly in Malaysia?
Foreign classification can be helpful, but the product should still be assessed according to Malaysian classification rules and MDA requirements.
Class A, B, C and D classification is one of the most important steps in Malaysia medical device registration.
The risk class affects the registration route, conformity assessment requirements, technical documentation, government fees, estimated timeline, product grouping and commercial market-entry strategy.
As a practical planning estimate:
| Medical Device Category / Route | Practical Planning Estimate |
| Class A medical device | Approximately 2 to 3 months |
| Class B, C and D medical devices with reference agency approval | Approximately 4 to 6 months |
| Class B, C and D medical devices without reference agency approval | Approximately 6 to 9 months |
For foreign manufacturers, correct classification should be completed before confirming project cost, distributor launch dates or registration strategy. Higher-risk devices should be planned more conservatively and should generally be supported by a complete technical file.
The choice of registration holder is also important. For manufacturers that want long-term control, flexibility to appoint multiple distributors and reduced distributor lock-in risk, appointing an independent Malaysia AR / medical device license holder is often the more strategic approach.
We support foreign medical device manufacturers with Malaysia medical device classification, MDA registration, authorized representative services, independent license holding, conformity assessment coordination, technical document review, distributor coordination and post-market compliance planning.
Whether your product is Class A, B, C or D, our team can help you assess the appropriate registration pathway, documentation requirements, expected timeline and market-entry structure.
Contact us today to discuss your Malaysia medical device registration and license holding requirements.
